Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.37 |
| ▸ | CA1 | P00915 | 5/20 | 0.37 |
| ▸ | CA2 | P00918 | 5/20 | 0.37 |
| ▸ | CA9 | Q16790 | 5/20 | 0.37 |
| ▸ | HRH2 | P25021 | 8/20 | 0.34 |
| ▸ | HRH1 | P35367 | 8/20 | 0.34 |
| ▸ | SUCNR1 | Q9BXA5 | 6/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18296410 | 1.00 | CA12 (0.37) | CA12CA1CA2CA9HRH2 | |
| SCHEMBL20036325 | 1.00 | CA12 (0.37) | CA12CA1CA2CA9HRH2 | |
| SCHEMBL18296428 | 0.98 | CA12 (0.39) | CA12CA1CA2CA9HRH2 | |
| SCHEMBL20207461 | 0.98 | CA12 (0.39) | CA12CA1CA2CA9HRH2 | |
| SCHEMBL20185004 | 0.98 | CA12 (0.39) | CA12CA1CA2CA9HRH2 | |
| SCHEMBL20036296 | 0.98 | CA12 (0.39) | CA12CA1CA2CA9HRH2 | |
| SCHEMBL20202478 | 0.98 | CA12 (0.36) | CA12CA1CA2CA9HRH2 | |
| SCHEMBL20202394 | 0.94 | CA12 (0.39) | CA12CA1CA2CA9HRH2 | |
| SCHEMBL20202386 | 0.93 | CA12 (0.40) | CA12CA1CA2CA9HRH2 | |
| SCHEMBL20207562 | 0.92 | CA12 (0.40) | CA12CA1CA2CA9HRH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10111437-B2 | Substituted guanidines as fungicides | NIPPON SODA CO., LTD. (JP) | 2018-10-30 | — | — | US | disclosed |
| US-20180146677-A1 | GUANICIDE COMPOUND AND FUNGICIDE | NIPPON SODA CO., LTD. (JP) | 2018-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180146677-A1 | GUANICIDE COMPOUND AND FUNGICIDE | GUCY1A2, GUCY1B2, GUCY1A1 | CA12 4537/4885CA1 3232/4885CA2 369/4885 |
| US-10111437-B2 | Substituted guanidines as fungicides | GUCY1A2, GUCY1B2, GUCY1A1 | CA12 4677/4885CA1 3910/4885CA2 529/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.